Treating pediatric depression in primary care: Coping with the patient’s blue mood and the FDA’s Black Box
May 01, 2006 | Print > Academic Article | For Providers | Depression | Medication | Suicide and Self-Harm
Provides guidance for primary care providers treating depression in children and adolescents following the FDA’s “black box warning” regarding an increased risk of suicidal ideation in depressed youth taking SSRI medications.
Reference:
Rappaport N, Bostic JQ, Prince J, Jellinek MS. Treating pediatric depression in primary care: Coping with the patient’s blue mood and the FDA’s Black Box. J of Pediatrics 2006; 48:567-8.
